Abbishek Sridharan | Drug delivery | Best Researcher Award

Mr. Abbishek Sridharan  | Drug delivery | Best Researcher Award

RWTH Aachen, India

Author Profile

 

🎓 Early Academic Pursuits

Abbishek Sridharan, born on April 25, 2002, began his academic journey with a keen interest in science and engineering. Raised in India, he completed his Senior Secondary Education at Kendriya Vidyalaya, Mysore, where he displayed strong analytical aptitude and an early inclination toward chemistry and materials. This led him to pursue a Bachelor’s degree in Chemical Engineering from Sri Venkateswara College of Engineering (SVCE), Anna University, Chennai between 2019 and 2023. During his undergraduate years, Abbishek was known for his curiosity, consistency, and academic rigor. He actively engaged in laboratory experiments and research, demonstrating exceptional skills in Electrochemistry, Process Technology, and Chemical Thermodynamics 🧪.

A defining aspect of his bachelor’s studies was his thesis project, which involved the preparation and antibacterial evaluation of rGO-based Zr/ZnO nanocomposites. This work not only sharpened his skills in Material Analysis and Surface Technology but also marked his entry into the world of nanotechnology and biomaterials 🔬.

👨‍🔬 Professional Endeavors

Currently, Abbishek is enrolled in the prestigious RWTH Aachen University, Germany, where he is pursuing a Master’s degree in Materials Engineering since October 2023. Here, he continues to deepen his knowledge and expertise in Biomaterials, Drug Delivery, and Corrosion Engineering. His ongoing research reflects a perfect blend of interdisciplinary collaboration and advanced material science.

In November 2024, Abbishek began working at BMW AG in Munich, Germany, further expanding his professional exposure. This industrial internship has allowed him to apply his academic knowledge to real-world materials engineering challenges, particularly in automotive technology—an area where surface properties and corrosion resistance are critical 🛠️.

His prior internships at GSK Factory (Hindustan Unilever Limited, Rajahmundry), Terra-Green Technologies Pvt. Ltd., and Aatral ESP at AIC AU Incubation Centre, Anna University were instrumental in providing hands-on industrial experience, introducing him to process engineering, sustainability practices, and material development in startup ecosystems.

🧬 Contributions and Research Focus

Abbishek’s research interests lie at the intersection of drug delivery systems, nanomaterials, and biomedical applications. He has contributed to the development of chitosan-based nanocomposites and graphene oxide hybrids integrated with metal oxides like CeO₂ and CuO for enhanced antibacterial and cytotoxicity applications. His work focuses on synthesizing smart materials that can offer controlled release, biocompatibility, and therapeutic efficiency 💊.

He has co-authored multiple publications, including:

  • “Synthesis of chitosan-based reduced graphene oxide-CeO₂ nanocomposites for drug delivery and antibacterial applications”

  • “Chitosan-Integrated Curcumin–Graphene Oxide/Copper Oxide Hybrid Nanocomposites for Antibacterial and Cytotoxicity Applications” (Published in MDPI Antibiotics, 2024)

These publications underscore his ability to bridge theory with application, contributing to the growing field of nanomedicine and biomedical engineering.

🏆 Accolades and Recognition

Abbishek has been recognized for his scientific acumen and presentation skills. He won the Best Paper Presenter Award in Chemistry at an International Conference, showcasing his ability to communicate complex research effectively. He has also been an active presenter at various symposiums, both national and international, representing his institutions with distinction.

His contributions have been featured in reputable journals such as Elsevier and MDPI, signaling a high level of scholarly merit. Additionally, Abbishek played an integral role in organizing an interdisciplinary symposium, exemplifying his teamwork and leadership skills 🏅.

🌍 Impact and Influence

Beyond technical skills, Abbishek excels in soft skills like public speaking, team coordination, and negotiation. His participation in Model United Nations (MUNs) reflects his ability to engage in diplomatic discussions, understand global issues, and work across cultures 🌐.

He is a technical researcher, a quick learner, and an adaptable professional, making him a valuable asset in both academic and industrial setups. His ability to collaborate in diverse teams has enriched the multidisciplinary nature of his work, influencing peers and inspiring junior researchers.

🔮 Legacy and Future Contributions

Abbishek Sridharan stands at the frontier of cutting-edge material engineering, with a vision to transform the way biomaterials are used in drug delivery and healthcare 🧫. He aspires to continue his research into nanocarriers, controlled-release systems, and surface-functionalized materials for clinical applications.

With a strong foundation in Microsoft Office, MatLab, ASPEN, Python, and even Machine Learning, Abbishek is well-positioned to innovate at the interface of materials science and artificial intelligence 🤖. His multidisciplinary training and global exposure uniquely equip him to contribute meaningfully to academia, industry, and public health.

His journey—from academic brilliance in India to impactful research in Germany—is a testament to his passion, perseverance, and purpose. As he continues to publish, present, and collaborate, his legacy will undoubtedly be one of innovation, mentorship, and global contribution ✨.

Notable Publications 

    1. Title: Chitosan-Integrated Curcumin–Graphene Oxide/Copper Oxide Hybrid Nanocomposites for Antibacterial and Cytotoxicity Applications
      Authors: Anandhavelu Sanmugam, Dr. Logesh Kumar Sellappan, Abbishek S, Swathy Manoharan, Ananda Babu Sairam, Abdulrahman I. Almansour, Subha Veerasundaram, Hyun-Seok Kim, Dhanasekaran Vikraman
      Journal: Antibiotics
      Year: 2024

Ananda Kumar Chettupalli | Pharmacy | Best Researcher Award

Dr. Ananda Kumar Chettupalli | Pharmacy | Best Researcher Award

Chettupalli Galgotias University, India

Author Profile

📚 Early Academic Pursuits

Dr. Chettupalli’s academic journey began with his foundational education in pharmacy. He obtained his Bachelor of Pharmacy degree in 2010 from Nirmala College of Pharmaceutical Sciences, affiliated with Acharya Nagarjuna University, where he gained a solid grounding in pharmaceutical principles and practices. During his undergraduate studies, Dr. Chettupalli demonstrated a keen interest in drug formulation and delivery systems, laying the groundwork for his future contributions to the field.Following his undergraduate studies, Dr. Chettupalli pursued his Master of Pharmacy (M.Pharm) in 2012 from A.M. Reddy College of Pharmacy, also affiliated with Acharya Nagarjuna University. Specializing in Pharmaceutics, he explored innovative methods of drug formulation. His M.Pharm thesis, titled “Development of Itraconazole Immediate Release Pellets by Using HPMC Loaded in Gelatin Capsules,” showcased his expertise in formulation science and his focus on enhancing drug solubility and bioavailability—challenges central to modern pharmacotherapy.

🧪 Research and Contributions

Dr. Chettupalli earned his Ph.D. in Pharmaceutical Sciences from Shri Jagdish Prasad Jhabarmal Tibrewala University in Rajasthan in 2016. His doctoral research, “Design and Characterization of Carvedilol Ethosomes as a Transdermal Drug Delivery System,” involved developing a transdermal delivery system for Carvedilol, a widely used cardiovascular drug. This innovative approach aimed to optimize therapeutic efficacy while minimizing side effects, emphasizing his focus on patient-centered pharmacology. His research marked an important step toward more effective and convenient treatment methods for chronic diseases through enhanced transdermal drug delivery systems.

🏆 Professional Endeavors and Experience

With a career spanning 12 years and 8 months, Dr. Chettupalli has gained extensive experience as an academic and researcher. Throughout his career, he has demonstrated a strong commitment to pharmaceutical education and research, bridging the gap between theory and practice. His experience in teaching has allowed him to mentor future pharmacists and pharmaceutical scientists, imparting both foundational knowledge and advanced skills in drug development and delivery systems.In addition to his role as an educator, Dr. Chettupalli has actively engaged in research focused on formulation science, nanotechnology, and transdermal systems, contributing to the ongoing evolution of pharmaceutical technology. His work on the development of immediate-release formulations and transdermal applications reflects his dedication to improving patient compliance and therapeutic outcomes through innovative drug delivery strategies.

🌍 Impact and Influence

Dr. Chettupalli’s research on transdermal drug delivery systems has contributed significantly to the advancement of non-invasive treatment modalities. By developing Carvedilol ethosomes for transdermal administration, he has provided a model for enhancing drug penetration through the skin barrier, potentially revolutionizing the treatment options available for patients with cardiovascular conditions. His contributions to formulation science have paved the way for more effective therapies with fewer adverse effects, which is particularly important in the management of chronic conditions.Moreover, Dr. Chettupalli’s influence extends beyond his immediate research, as his expertise in formulation and nanotechnology continues to inspire a new generation of pharmaceutical scientists. His commitment to bridging clinical relevance with academic rigor serves as a model for aspiring researchers in the field.

🏅 Accolades and Recognition

Over the years, Dr. Chettupalli has received recognition for his contributions to the field of pharmaceutics. His work has been appreciated by academic peers and students alike, who recognize his dedication to quality research and his skill in making complex topics accessible. While specific awards and honors may not be listed here, Dr. Chettupalli’s ongoing influence as an educator and researcher serves as a testament to his excellence in the field.

💡 Legacy and Future Contributions

Dr. Chettupalli’s impact on pharmaceutical sciences, particularly in the area of drug delivery systems, is likely to endure for years to come. As he continues his work in pharmaceutics, he is poised to make further contributions to transdermal drug delivery and nanotechnology applications. His research on ethosomes has the potential to inspire further studies on the transdermal delivery of other therapeutic agents, potentially offering new treatments for a range of conditions.Looking to the future, Dr. Chettupalli is expected to expand his research on innovative drug delivery mechanisms, possibly incorporating advanced nanotechnology and biodegradable polymers to develop environmentally sustainable and patient-friendly pharmaceuticals. His career reflects a dedication to both scientific advancement and patient welfare, and his work will likely continue to influence the fields of formulation science and clinical pharmacology.

🌟 Conclusion: A Lasting Contribution

Dr. Ananda Kumar Chettupalli’s career in pharmaceutical sciences exemplifies the power of combining academic knowledge with practical innovation. From his early studies in pharmacy to his specialized work in transdermal drug delivery, he has contributed significantly to the fields of pharmaceutics and drug formulation. His ongoing dedication to education and research underscores his commitment to improving healthcare and advancing the pharmaceutical sciences, and his work will continue to benefit both students and patients for years to come.

Citations

A total of 228 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         228
  • h-index           19
  • i10-index        09

Notable Publications 

  • “Improved Transdermal Delivery of Anti-hypertensive Drug Loaded Nanostructured Lipid Carriers: Statistical Design, Optimization, Depiction and Pharmacokinetic Assessment”
    • Authors: Chettupalli, A.K., Avula, P.R., Chauhan, V.
    • Journal: Current Drug Therapy, 2024.
  • “Design Formulation of Nanospanlastic Novel Carriers as a Promising Approach to Enhanced Bioavailability in Intranasal Drug Delivery for Sinusitis: Statistical Optimization and In vitro and In vivo Characterization”
    • Authors: Chettupalli, A.K., Ajmera, S., Kuchukuntla, M., Palanivel, V., Katta, S.
    • Journal: Current Nanomedicine, 2024.
  • “Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations”
    • Authors: Unnisa, A., Chettupalli, A.K., Alazragi, R.S., Mohamed, O.A., Hussain, T.
    • Journal: Pharmaceuticals, 2023.
  • “Quality by Design Approach for Preparation, Characterization, and Statistical Optimization of Naproxen Sodium-loaded Ethosomes via Transdermal Route”
    • Authors: Chettupalli, A.K., Ajmera, S., Amarachinta, P.R., Manda, R.M., Jadi, R.K.
    • Journal: Current Bioactive Compounds, 2023.
  • “In silico elucidation of plausible anti-obesity activity by Withaferin-A compound targeting alpha-amylase”
    • Authors: Alafnan, A., Chettupalli, A.K., Unnisa, A., Anupama, B., Lakshmi, K.N.V.C.
    • Journal: European Review for Medical and Pharmacological Sciences, 2023.